Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
From - G2 Compliance Advisor
A Florida clinic has settled a False Claims Act case relating to drug testing for $7.4 million. Quantitative drug tests that…
From - G2 Compliance Advisor
When asked why he robbed banks, the notorious outlaw Willie Sutton famously replied: "Because that's where they keep…
From - G2 Compliance Advisor
When the Centers for Medicare & Medicaid Services (CMS) announced in mid-June the final rules governing the Protecting the…
From - G2 Compliance Advisor
Theranos has announced that it is appealing the Centers for Medicare & Medicaid's threatened sanctions. The announcement also indicated that…
From - G2 Compliance Advisor
The Office of Inspector General's Compliance Program Guidance for Clinical Laboratories includes among its seven elements for a comprehensive compliance program…
From - G2 Compliance Advisor
While labs may draft a comprehensive compliance plan and policies and procedures, those policies, procedures and plan can be a liability if…
From - G2 Compliance Advisor
Hiring and firing staff are difficult challenges. While there are many factors to consider in making either decision, compliance should be front of mind in…